Intrust Bank Na Biogen Inc. Transaction History

Intrust Bank Na

$936 Million
Q2 2024

A detailed history of Intrust Bank Na transactions in Biogen Inc. stock. As of the latest transaction made, Intrust Bank Na holds 1,591 shares of BIIB stock, worth $293,984. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,591

Previous 1,726 7.82%

Holding current value

$293,984

Previous $372,000 1.08%

% of portfolio

0.04%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$190.52 - $236.72 $25,720 - $31,957	-135 Reduced 7.82%	1,591 $368,000
Q1 2024 May 09, 2024	SELL	$212.02 - $267.71 $49,188 - $62,108	-232 Reduced 11.85%	1,726 $372,000
Q4 2023 Feb 05, 2024	BUY	$222.59 - $267.94 $26,933 - $32,420	121 Added 6.59%	1,958 $506,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $25,330 - $28,589	-100 Reduced 5.16%	1,837 $472,000
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $28,901 - $33,396	-105 Reduced 5.14%	1,937 $551,000
Q1 2023 May 04, 2023	BUY	$256.56 - $292.34 $133,924 - $152,601	522 Added 34.34%	2,042 $567,000
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $60,333 - $73,306	239 Added 18.66%	1,520 $420,000
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $15,769 - $21,745	81 Added 6.75%	1,281 $342,000
Q2 2022 Aug 16, 2022	BUY	$187.54 - $223.02 $6,001 - $7,136	32 Added 2.74%	1,200 $244,000
Q1 2022 May 10, 2022	BUY	$193.77 - $244.14 $36,428 - $45,898	188 Added 19.18%	1,168 $246,000
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $87,552 - $112,518	-391 Reduced 28.52%	980 $235,000
Q3 2021 Nov 04, 2021	BUY	$282.99 - $369.05 $3,395 - $4,428	12 Added 0.88%	1,371 $388,000
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $31,598 - $50,594	-122 Reduced 8.24%	1,359 $470,000
Q1 2021 Jun 02, 2021	SELL	$242.95 - $284.63 $107,140 - $125,521	-441 Reduced 22.94%	1,481 $414,000
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $67,334 - $101,354	-285 Reduced 12.91%	1,922 $470,000
Q3 2020 Nov 05, 2020	SELL	$264.77 - $305.71 $98,229 - $113,418	-371 Reduced 14.39%	2,207 $627,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $30,521 - $40,420	-118 Reduced 4.38%	2,578 $689,000
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $199,486 - $253,051	742 Added 37.97%	2,696 $853,000
Q4 2019 Feb 07, 2020	BUY	$220.06 - $304.07 $22,666 - $31,319	103 Added 5.56%	1,954 $580,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $1,956 - $2,194	-9 Reduced 0.48%	1,851 $431,000
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $95,171 - $104,906	-434 Reduced 18.92%	1,860 $435,000
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $32,289 - $50,505	-149 Reduced 6.1%	2,294 $542,000
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $26,179 - $33,158	94 Added 4.0%	2,443 $735,000
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $45,200 - $59,109	154 Added 7.02%	2,349 $830,000
Q2 2018 Aug 08, 2018	SELL	$257.52 - $306.91 $53,049 - $63,223	-206 Reduced 8.58%	2,195 $637,000
Q1 2018 May 03, 2018	SELL	$260.13 - $367.91 $10,665 - $15,084	-41 Reduced 1.68%	2,401 $657,000
Q4 2017 Feb 08, 2018	BUY	$307.64 - $344.58 $39,685 - $44,450	129 Added 5.58%	2,442 $778,000
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $650,299 - $762,572	2,313	2,313 $724,000

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.

Account